outpatients with major affective disorder , unipolar depressed type ( n=101 ) , were treated in a 4-week placebo-controlled double-blind study to compare the efficacy and safety of fluvoxamine , a new serotonin reuptake inhibitor antidepressant , with imipramine and placebo .
C0003289
antidepressant
C0020934
imipramine